Lipid Metabolism WUD 2018 - aaf-online.org · science research interests include clinical disorders...

WEILL CORNELL SEMINAR in

SALZBURG

in collaboration with

International Atherosclerosis Society

"Lipid Metabolism"

September 16 – 22, 2018

Table of Contents

1. Faculty & Group Photo

2. Schedule

3. Faculty Biographies

4. Fellows Contact Information

5. Diaries

a Program of the

SALZBURG WEILL CORNELL / IAS SEMINAR LIPID METABOLISMSeptember 16 - 22, 2018

Faculty Photo (L-R)Rekha Kumar, MD; Gilles Lambert, MD; Antonio M. Gotto Jr., MD;

Philip Barter, MD; Emanuela Folco, PhD; Michal Vrablik, MD; Jennifer Robinson, MD

30 fellows from 26 different countries and regions

6 faculty members from the United States, France & Australia

18 lectures and 4 workshops given by faculty

29 interesting case presentations by fellows

7 excellent case presentations selected by faculty

Group Photo of Faculty and Fellows

Sunday Monday Tuesday Wednesday Thursday Friday Saturday

16.09.2018 17.09.2018 18.09.2018 19.09.2018 20.09.2018 21.09.2018 22.09.2018

LDL and CVD:

Epidemiology and Trials

Adverse Effects of

Statins and Statin

Intolerance

Obesity: Behavioral,

Nutritional and Medical

Treatments

Metabolism and

Protective Properties of

HDL

Antonio M. Gotto Jr., MD,

DPhil

Jennifer G. Robinson, MD,

MPHRekha B. Kumar, MD

Philip Barter, MD, MBBS,

PhD, FRACP

Lipid/ Lipoprotein

Structure and

Metabolism (Overview)

Triglyceride and CVD

Epidemiology and

Clinical Trials

Epidemiology and

Causes of ObesityGenetic Dyslipidemias

Lipoprotein (A):

Metabolism,

Atherogenic Properties

and Therapeutic Target


PhD, FRACPMichal Vrablik, MD, PhD Rekha B. Kumar, MD


DPhilGilles Lambert, MD

Metabolism and

Atherogenic Properties

of LDL

HDL and CVD

Epidemiology and

Clinical Trials

Agents to Reduce LDL

(Present and Future)

Role of Lifestyle

Intervention in

Prevention and

Management of CVD

Lipid Management

Guidelines


DPhil


PhD, FRACP


MPH


MPH


MPH

Inflammation and CVD

Special Groups: Gender,

Old Age, Children,

Pregnancy

Evaluation and

Assessment of the Adult

Patient with Obesity

PCSK9: From Basic

Science to Therapeutic

Agent

Q&A Session: Any

Issues

Michal Vrablik, MD, PhD Michal Vrablik, MD, PhD Rekha B. Kumar, MD Gilles Lambert, MD All Faculty

DINNER

FACULTY DINNER IN

PRIVATE HOME

Fellows' Case

Presentations

17:00 - 17:15OMI/AAF Presentation

Post-Seminar Test

Evaluation & Discussion

LUNCH

COFFEE BREAK COFFEE BREAK COFFEE BREAK

LUNCH LUNCH LUNCH LUNCH

Free Afternoon

Workshop:

Identification and

Management of Patients

with Familial

Hypercholesterolemia (FH)

Fellows' Case

Presentations

20:00 21:00

FAREWELL RECEPTION

GRADUATION DINNER

Certificated AwardedDINNER DINNER

WELCOME RECEPTION

& DINNER

DINNER

20:30 – 21:30CHAMBER MUSIC

CONCERT

FACULTY MEETING TO

REVIEW THE WEEK

19:00 20:00

BREAKFAST

09:0008:00

14:00

10:00 10:30

Introductions

Pre-Seminar Test

12:30

DEPARTURESBREAKFASTBREAKFASTBREAKFASTBREAKFAST

14:00 15:00

15:00 16:00

16:00 17:00

2018 Salzburg Weill Cornell/ IAS Seminar in Lipid Metabolism

Sunday 16 September - Saturday 22 September 2018

17:00 18:00

18:00 19:00

09:00 10:00

10:30 11:30

11:30 12:30

ARRIVALS

COFFEE BREAK COFFEE BREAK

07:00 08:00

WEILL CORNELL SEMINAR

in SALZBURG

"Lipid Metabolism"

September 16 – 22, 2018

FACULTY

Wolfgang Aulitzky, MD is the Medical Director of the American Austrian Foundation. He is Associate Dean for International Medicine and Distance Learning, Adjunct Prof. of Clinical Urology and Adjunct Prof. of Clinical Reproductive Medicine at the Weill Medical College of Cornell University/New York Presbyterian Hospital. In 2016, he was appointed Adjunct Professor of Pediatrics in the Associated Faculty of the Perelman School of Medicine at the Children’s Hospital of Philadelphia. He is also Associate Prof. of Urology at the Medical University of Innsbruck and Visiting Professor at the Medical University of Vienna. Amongst others he is a member of the American, German and Austrian Societies of Urology and was awarded the Zuckerkandlpreis of the Austrian Society of Urology in 1989. In 1995 he received the Silver Medal, in 2007 the Golden Medal for Merits to the Republic of Austria and in 2014 the cross of honor of the Land Salzburg. As Director of the Medical Program of the American Austrian Foundation he has initiated the Open Medical Institute, a scientific and educational collaboration of Weill Cornell and the NewYork Presbyterian Hospital, the Children Hospital of Philadelphia, Duke University, Columbia University, the Cleveland Clinic and leading hospitals in Austria. Dr. Aulitzky earned his medical degree at the University of Innsbruck in 1977, was a research associate at the University of Uppsala, Sweden and the Rockefeller University, New York. He received his training as an urologist at the University of Innsbruck and the General Hospital of Salzburg. He is the author of more than 140 publications on Urology, Andrology and Health Care issues and is co-author of books on basic and clinical urology/andrology. Wolfgang Aulitzky, MD Director, Open Medical Institute American Austrian Foundation Associate Dean and Gerhard Andlinger Professor for International Medicine & Distance Learning Adjunct Professor of Clinical Urology Adjunct Professor of Clinical Reproductive Medicine Weill Medical College of Cornell University Adjunct Professor of Pediatrics Perelman School of Medicine at the Children’s Hospital of Philadelphia Associate Professor of Urology Medical University of Innsbruck, Austria Kärntner Straße 51/II/Top 4 1010 Vienna Austria Phone: +43-1-533-8658 Fax: +43-1-533-8658-10 Email: [email protected]

Antonio M. Gotto Jr., MD, DPhil (Course Director) is Dean Emeritus of Weill Cornell Medicine in New York, New York, where he is also the Provost for Medical Affairs Emeritus of Cornell University. From 1997-2011, Dr. Gotto was the Stephen and Suzanne Weiss Dean at Weill Cornell and Provost for Medical Affairs at Cornell University. Dr. Gotto’s postgraduate work included doctoral studies at Oxford University in England, as a Rhodes Scholar, and residency training at the Massachusetts General Hospital in Boston, Massachusetts. In the field of atherosclerosis, his basic science research interests include clinical disorders of lipid transport and the structure, metabolism, and function of lipoproteins and apolipoproteins. He and his associates were the first to achieve complete synthesis of a plasma apolipoprotein (apo C-I); they also determined the complete cDNA and amino acid sequence of apo B-100, one of the largest proteins ever sequenced and a key protein in atherosclerosis. Dr. Gotto has played a leading role in several landmark clinical trials demonstrating that cholesterol-lowering drug treatment can reduce the risk for heart disease. A lifelong supporter of educational efforts aimed at cardiovascular risk reduction, Dr. Gotto has been National President of the American Heart Association and President of the International Atherosclerosis Society. He is a member of the Institute of Medicine and the American Academy of Arts and Sciences. Dr. Gotto has contributed more than 500 scholarly articles and books to the medical literature, and he is coauthor of the Living Heart series of books that explain the origins and treatment of cardiovascular disease to the general public. Antonio M. Gotto Jr., MD, DPhil Dean Emeritus Weill Cornell Medicine New York-Presbyterian Hospital 1305 York Avenue, Y-805 New York, NY 10021 USA Phone: +1-646-962-6038 Fax: +1-646-962-8424 Email: [email protected]

Philip Barter, MBBS, PhD, FRACP (Co-Course Director) is immediate Past President of the International Atherosclerosis Society. He is a Professor of Medicine at the University of New South Wales in Sydney Australia. He graduated in medicine from the University of Adelaide and gained his PhD from the Australian National University. He has held positions in research institutes and universities in Australia and the US and is currently based at the University of New South Wales in Australia where he holds a position as Conjoint Professor of Medicine. He is a fellow of the Royal Australasian College of Physicians. His basic research interests are plasma lipids and lipoproteins, specifically high density lipoproteins, the factors that regulate them and the mechanism by which they protect against cardiovascular disease. His clinical research involves participation in clinical trials of lipid-lowering agents. He was a member of the steering committees of the FIELD study, the TNT Study, was co-chair of steering committee of the DEFINE study and was chairman of the steering committee of the ILLUMINATE trial. He is currently a member of the steering committees of the REVEAL HPS-3 TIMI-55 trial and the ACCELERATE trial. He has published more than 350 peer-reviewed research papers on plasma lipids and lipoproteins, their metabolism, regulation, function and relationship to atherosclerosis. He has also written handbooks on HDL and CETP inhibitors. Philip Barter, MBBS, PhD, FRACP Immediate Past President, International Atherosclerosis Society School of Medical Sciences University of New South Wales Sydney, NSW, 2052 Australia Email: [email protected]

Rekha B. Kumar, MD is an Assistant Professor of Medicine at the Weill Cornell Medical College. She is an Attending Endocrinologist specializing in the diagnosis and treatment of various endocrinology disorders, including obesity and weight management. Dr. Kumar is board certified in Internal Medicine, Endocrinology, Diabetes and Metabolism, and is a Diplomate of the American Board of Obesity Medicine. Dr. Kumar has authored several papers and textbook chapters on the topic of Obesity Management. Dr. Kumar enjoys educating physicians on various aspects of obesity medicine ranging from etiologies of obesity to new pharmacologic therapies. Dr. Kumar serves as the Program Director of the Obesity Medicines Fellowship program at the Weill Cornell Medical College and has designed a year-long curriculum to prepare physicians for a career in Obesity Medicine. She has lectured to physicians around the United States and addressed policy makers on Capitol Hill on the importance of treating obesity as a disease. Dr. Kumar has traveled abroad to India, China, and Tanzania in order to teach medicine and learn about the effects of urbanization on diabetes and metabolic health. Rekha B. Kumar, MD Assistant Professor of Medicine Department of Endocrinology, Diabetes, and Metabolism Weill Cornell Medical College 1165 York Avenue New York, NY 10065 USA Phone: +1-646-962-2111 Fax: +1-646- 962-0159 Email: [email protected]

Gilles Lambert, MD is Professor in Cell Biology and Biochemistry at the University of La Réunion Medical School (France) and a group leader at Inserm UMR1188 DéTROI laboratory. Pr. Lambert was awarded a PhD in Pathophysiology from the University of Paris in 1998. He specialized in lipidology, first as a post-doctoral fellow at the Molecular Disease Branch of the National Institutes of Health (Bethesda MD, USA) under the supervision of Dr. H Bryan Brewer Jr. and as a senior research fellow at the Heart Research Institute (Sydney NSW, Australia) in the lipid research group led by Pr. Philip Barter. In recent years, Pr. Lambert has conducted seminal research projects on PCSK9, a protein that targets the LDL receptor for intracellular degradation, and as such, the target of novel cholesterol lowering therapies: the PCSK9 inhibitors. He has received several competitive research grants in Australia and in France to study the cardiovascular benefits and potential side effects of PCSK9 inhibition. Pr. Lambert current research interests are to elucidate the specific role of PCSK9 in insulin producing beta-cells and to understand the cellular pathways by which PCSK9 modulates the circulating levels of lipoprotein (a), a highly atherogenic lipoprotein species. Gilles Lambert, MD Professor in Cell Biology and Biochemistry University of La Réunion Medical School Inserm UMR 1188 2, Rue Maxime Riviere 97491 Sainte- Clotilde France Phone: +262-262-938-807 Email: [email protected]

Jennifer G. Robinson, MD, MPH is a Professor in the Departments of Epidemiology and Medicine (Division of Cardiology), and Director of the Prevention Intervention Center at the University of Iowa, Iowa City, Iowa. As an active researcher, Dr. Robinson has performed numerous clinical trials sponsored by the National Institutes of Health and the pharmaceutical industry. She has conducted extensive research on a wide range anti-atherosclerotic and metabolic agents, including lipid-modifying, anti-inflammatory, antihypertensive, weight loss, and diabetic treatments as well as postmenopausal hormone therapy. She is the principal investigator for the Women’s Health Initiative (WHI) at the University of Iowa. Her current research interests include clinical trials to cure atherosclerosis. Dr. Robinson has published over 200 peer-reviewed articles in the area of lipids-modifying drugs, cardiovascular risk stratification, and cardiovascular prevention, with multiple recent publications in the New England Journal of Medicine, JAMA, Journal of the American College of Cardiology and Circulation. She has lectured widely on preventive cardiology and the diagnosis and treatment of disorders of lipid metabolism in the US and internationally. She was Vice Chair of the 2013 ACC/AHA cholesterol guideline, and a member of the 2013 ACC/AHA risk assessment guideline. In addition to long involvement in multiple American Heart Association (AHA) committees, recent leadership roles include serving as Chair of the Lifestyle Track for the American Heart Association Scientific Sessions. She is the 2017 Chair of the National Forum for Heart Attack and Stroke Prevention, a consortia of over 90 governmental, public health, academic, and industry groups. While at the University of Minnesota in Minneapolis, Dr. Robinson received her medical degree and completed an Internal Medicine residency with the College of Medicine, and received a Master’s of Public Health from the College of Public Health. She is a diplomate of the American Boards of Internal Medicine and Clinical Lipidology and a Fellow of the American Heart Association. Jennifer G Robinson MD MPH Professor, Departments of Epidemiology & Medicine Director, Prevention Intervention Center Department of Epidemiology 145 N Riverside Dr S455 CPHB Iowa City, IA 52242 USA

Phone: +1-319-384-1563 Email: [email protected]

mailto:[email protected]

Michal Vrablik MD, PhD is currently a Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic. After graduating from the 1st Faculty of Medicine of Charles University in Prague in 1997, he obtained his PhD in 2001 (thesis on “Familial Dyslipidemias – Clinical and Genetic Aspects”). In 2011 he was appointed an Associate Professor in Internal Medicine, becoming full Professor in 2018. He is most recently involved in studying cardiovascular prevention strategies in different population groups and pharmacogenetic studies. He is the chairman of the Czech Atherosclerosis Society, member of the board of the Czech Society of Internal Medicine and the board of the working group of preventive cardiology of the Czech Society of Cardiology. He participates in the FH screening MedPed program, being a leader of the project’s national center. He served as a member of the Executive Committee of the European Atherosclerosis Society between 2012 and 2016, currently he continues cooperation with EAS as a member of its Educational Platform Committee. He is a member of the editorial board of PCSK9 Forum. In 2018, he joined the steering committee of the International Lipid Expert Panel. He has served as a principal investigator and investigator in more than forty research projects on familial dyslipidemias and cardiovascular disease risk. Dr. Vrablik served as a lecturer at the EAS Summer School between 2007 and 2009. Since 2010 he has co-organized International Atherosclerosis Research School endorsed by the EAS and IAS. He was a member of organizing committees of the 75th EAS congress in Prague in 2005 and the president of the 85th EAS congress held in Prague in 2017. In 2005-2006 he received a research grant from the Czech Society of Cardiology and joined Healthy Heart Program of St. Paul´s Hospital, Vancouver, Canada. He worked at the Cardiovascular Risk Reduction and Metabolic Syndrome Clinics with prof. Jiri Frohlich. Dr. Vrablik has authored and co-authored more than 200 papers in peer-reviewed scientific journals; he is also a member of editorial board as well as a reviewer for several national and international journals. Michal Vrablik, MD, PhD Professor of Internal Medicine 3rd Dept. of Internal Medicine 1st Faculty of Medicine Charles University U Nemocnice 1 12808 Prague 2 Czech Republic Phone: +420-224-962-122 Email: [email protected]

mailto:[email protected]

WEILL CORNELL SEMINAR

in SALZBURG

"Lipid Metabolism"

September 16 – 22, 2018

FELLOWS

a Program of the

Shahnoza Abdulghani, MD

State City Hospital named after AkmedovAbai 3, known as soviet streetDushanbe, Tajikistan

E-Mail:[email protected]:+99-2-935494690

Filip Andrle, MD

Military University Hospital PragueU vojenske nemocnice 1200169 02 Prague, Czech Republic


Aiymkul Ashimkhanova, MD, MSc

Nazarbayev University / UME, National Oncology & Transplanet CenterKerey Zhanibek khan street 5/1010000 Astana, Kazakhstan


Natia Asitashvili, PhD

National Center of Surgery5, Chachava Str.0159 Tbilisi, Georgia

E-Mail:[email protected]:+995593742419

Volha Ivanauna Auchynnikava, MD

Belarusian Medical Academy Department EndocrinologyPetrusia Brovki220114 Minsk, Belarus


a Program of the

Edin Begic, MA, MD

General Hospital „Prim. dr. Abdulah Nakas“Kranjceviceva 1271000 Sarajevo, Bosnia and Herzegovina


Urska Bregar, MD, PhD

University Clinical CenterZaloska 71000 Ljubljana, Slovenia


Ruden Cakoni, MD

Hospital „Mother Theresa“Rruga Dibres1001 Tirana, Albania

E-Mail:[email protected]:00355694326705

Veronica Cernelev, MD

USMF „Nicolae Testemitanu“Testemitanu 292075 Chisinau, Republic of Moldova


Ivette Cruz Bautista, MD

National Institute of Medical Science and NutricionVasco De Quiroga 1514200 mexico, Mexico

E-Mail:[email protected]:+52-5-554870999 / 6221

a Program of the

Marija Friscic, MD

Clinical Center of Montenegro, Institute for Childrens DiseaseLjubljanska bb81000 Podgorica, Montenegro

E-Mail:[email protected]:+382 69226630

Urte Gargalskaite, MD

Vilnius University Hospital Santaros KlinikosSantariskiu Str. 208661 Vilnius, Lithuania

E-Mail:[email protected]:+370 65248864

Olena Volodymyrivna Gerasymenko, PhD

National University of PharmacyPushkinska str. 2761002 Kharkiv, Ukraine


Guillermina Gomez Navarro, MD

Hospital de Pediatria CMMOBelisario Dominguez 73544340 Guadalajara, Mexico

E-Mail:[email protected]:52-1-3312929072

Jose Gotes Palazuelos, MD, MSc

Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranVasco de Quiroga 15, Belisario Dominguez Seccion XVI, Tlalpan14080 Mexico City, Mexico


a Program of the

Martin Hajsl, MD, PhD

Military University HospitalU Vojenske nemocnice 120010600 Prague, Czech Republic


Meri Armen Hambardzumyan, MD

Hospital of Medical Department of PoliceNver Sarafyan 140060 Yerevan, Armenia

E-Mail:[email protected]:+399-93191600

Ingrid Hein, MD

East-Tallinn Central HospitalRavi 1810138 Tallinn, Estonia


Huriya Hisamova, PhD

National TB project37 building 1 Bokhtar street 7 level VEFA Center734002 Dushanbe, Tajikistan


Irodakhon Inoyatkhodjaeva, MD

Scientific & Practical Center of EndocrinologyMirzo Ulugbek100125 Tashkent, Uzbekistan


a Program of the

Elena Karelkina, MD

Almazov National Medical Research Centre2, Akkuratova str197341 St. Petersburg, Russian Federation


Andrea Komornikova, MD

Comenius Univesity HospitalMickiewiczova 1381369 Bratislava, Slovakia

E-Mail:[email protected]:00421-911516737

Nadira Kushubakova, MD

National Center of Cardiology & Therapy named after M.MirrahimovTogolok Moldo 3720040 Biskkek, Kyrgyzstan


Tatyana Leonovich, MD

Scientific Research Institute of Cardiology & Internal DiseasesAiteke bi 120050000 Almaty, Kazakhstan


Mihael Mihnev, MD

UMHAT Alexandrovska1 Sv. Georgi Sofiyski Blvd1431 Sofia, Bulgaria


a Program of the

Argjent Mucha, MD, PhD

University Clinic of EndocrinologyVodnjanska 10001000 Skopje, Republic of Macedonia


Gloria Amaleck Ngajilo, MD

Benjamin Mkapa HospitalUniversity of Dodoma255 Dodoma, United Republic of Tanzania


Aleksandra Sesiuk, MD

Centrum Medyczne HCP Sp. z o.o.28 Czerwca 1956r. nr 19461-485 Poznan, Poland


Oksana Sirenko, PhD

SE Dnipropetrovsk Medical AcademyVernadskogo 949044 Dnipro, Ukraine

E-Mail:[email protected]:+38-0507432016

Jurate Zupkauskiene, MD

Vilnius University Hospital Santaros KlinikosSantariskiu Street 2LT-08661 Vilnius, Lithuania


SEMINAR DIARY FROM FELLOWDiary of Meri Armen Hambardzumyan, MD

Hospital of Medical Department of PoliceYerevan, Armenia

September 16 – 22, 2018

The sound of the train and the view out of the window were like amazing Nocturne Morts that I haven’t seen before, brought me to Salzburg.When I pressed the Button of the gates of Schloss Arenberg, I did not realised that in from of me the gates would not only open to the Schloss but also many other paths will open to me.In the seven day of being here, I found all colours of the rainbow and a few I will mention.

Blue: I enjoyed the lectures, full of new information and spiced with intelligent humour thanks to which I have never been tired during the seminar.

Yellow: When for the first time surprisingly I saw the dog just in Seminar Hall looking at my eyes. He was Jojo with whom we became friends later.

Orange: Reminds me of the sunny faces and kind responses of all the staff.

Green: when I attended a very interesting workshop with professor Barter and received a compliment from him at the end.

And I want to finish my notes with

Red: Which expresses all my passion to science, culture and humanity, which I found during this seminar.

I’m going to take all these colours to Armenia to share them with those who really need the Rainbow!

Meri Armen Hambardzumyan, MD (Armenia)

SEMINAR DIARY FROM FELLOWDiary of Natia Asitashvili, PhD

National Center of SurgeryTbilisi, Georgia

September 16 – 22, 2018

I arrived in Salzburg at late night. It was my second visit in this beautiful town and I was looking forward to see the unique combination of ancient and modern architecture and beautiful nature again. I arrived at Schloss Arenberg, filled in some formal papers and got the room key and a schedule of the week. From this moment a very interesting and pleasant week started. I like the location and appearance of the building, very nice garden, the pleasant atmosphere inside the school, and the cozy bedroom and the polite staff.

Next day I spent just in walking in the Center of Salzburg, enjoying the beautiful views of town, walked by Salzach river and returned to Schloss Arenberg to prepare for welcome reception where we met faculty members and each other.

17 September: In the morning (after a very short night), all participants met at breakfast and began to share the features of their national breakfast. After the delicious breakfast seminar started. We wrote our pre-test and we had an opportunity to listen to most professional lecturers and scientists, very respectable people with charming nature. I want to express my gratitude to such respected speakers and great scientists as Professors Philip Barter, Antonio Giotto, Michal Vrablic, Dr. Rekha B. Kumar, Dr. Jennifer G. Robinson, Dr. Gilles Lambert. It was very important that they explained the topic from the most basic and simplest things to the most difficult topics to be understandable for everyone and I am very grateful for this, as I didn’t remember some of even the simplest topics from basic medicine. They underlined the significance of every topic and showed the direction of how we could use this information in our clinical practice. PCSK9 and its inhibitors were especially interesting to me. Of course I had read some information about it, but as this group of drugs is not registered in Georgia yet I did not pay much attention. Now I was introduced to such an interesting and important group and feel prepared to use them properly soon, when they will be available in Georgia. Summarizations of European and American guidelines about treatment evaluations and follow up of hyperlipidemias was very important. I think it will help me in my daily practice.

On Tuesday and Thursday, case presentations of fellows were presented. They all were very interesting. The Faculty discussed our cases with us and other fellows and gave correct directions and advices. The breaks between lectures as well as the dinner in the evening gave us plenty of opportunity to relax and get to know each other better and form friendships. We got to spend time together and with the faculty. They even offered to stay in touch, so we could ask them for help if we had difficult cases and needed support. I want to thank them again for this.Besides lectures, we had a chance to enjoy our stay in Salzburg. We had a chance to go sightseeing, even to attend Octoberfest, which was very interesting to us.

We had a chance to enjoy chamber music concert in the evening on September 20. A young talented pianist, Andrei Gogolan performed music by W. A. Mozart, L. van Beethoven, J. Haydn, R. Schumann and G. Enescu. I was very happy to have this

chance as I didn’t want to leave Austria - country of music and art - without getting pleasure from classical music.

Day 6. September 21, Friday. The last day of the AAF Lipid Metabolism Seminar. We had several interesting lectures again. Then we wrote our post-test and after finishing the papers professors discussed the answers with us to not leave anything unclear and give us one more important lesson. It appeared that all of us could answer the test much better, as it was expected after such perfect training. In the evening, we had a farewell reception and graduation dinner where certificates were awarded and we had one more chance to take photos with our already beloved and respected professors, great scientists and lecturers. So the seminar ended and I left with many plans and ideas of how to implement the information we got here in clinical practice. I think that it is also very important to increase the activity of the local Open Medical Institute, to hold symposiums, translate materials to native languages for other doctors. I would love to take part in such activities.

I would like to thank the Open Medical Institute, all the Faculty of the AAF Lipid Metabolism Seminar and the whole organization team for the perfect Lipid Metabolism Course, for the very interesting, high level and important information they gave us, for the patience and openness to our questions, for their a collaborative and friendly attitude. I would like to thank all my colleagues from so many countries for forming a beautiful group in such a short time and spend an unforgettable week together. And once more I want to express my greatest gratitude and respect towards all faculty and the organization team.

With best wishes and regards Natia Asitashvili, MD (Georgia)

Lipid Metabolism WUD 2018 - aaf-online.org · science research interests include clinical disorders...

Documents

Transcript of Lipid Metabolism WUD 2018 - aaf-online.org · science research interests include clinical disorders...